Literature DB >> 26114251

Prostate Imaging--An Update.

T Franiel1, P Asbach2, U Teichgräber1, B Hamm2, S Foller3.   

Abstract

UNLABELLED: New technical and clinical developments of sonography and magnetic resonance imaging include improved detection, localization and staging as well as active surveillance of prostate cancer. Multiparametric MRI can best answer these typical clinical questions. However, ultrasound elastography seems to be suitable for the detection of significant prostate cancer as well. The structured reporting system for multiparametric MRI of the prostate according to PI-RADS Version 1 led to improved and reproducible diagnosis of prostate cancer. The new PI-RADS Version 2 aims to minimize the limitations of Version 1 and make PI-RADS standardization more globally acceptable. KEY POINTS: The detection, staging, and active monitoring of prostate cancer are common clinical questions. The best method for answering these questions is multiparametric MRI. Ultrasound elastography also seems to be suitable for the detection of significant prostate cancer. The new PI-RADS Version 2 claims to eliminate the limitations of PI-RADS Version 1 and to allow globally recognized standardized diagnostic reporting. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26114251     DOI: 10.1055/s-0035-1553162

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  4 in total

1.  [Focal therapy of prostate cancer].

Authors:  R Ganzer; T Franiel; J Köllermann; T Kuru; D Baumunk; A Blana; B Hadaschik; J von Hardenberg; T Henkel; K-U Köhrmann; U-B Liehr; S Machtens; A Roosen; G Salomon; H-P Schlemmer; L Sentker; J Wendler; U Witzsch; M Schostak
Journal:  Urologe A       Date:  2017-10       Impact factor: 0.639

Review 2.  The role of diagnostic ultrasound imaging for patients with known prostate cancer within an active surveillance pathway: A systematic review.

Authors:  Pamela Parker; Maureen Twiddy; Paul Whybrow; Alan Rigby; Matthew Simms
Journal:  Ultrasound       Date:  2021-04-15

3.  T2 mapping for the characterization of prostate lesions.

Authors:  Tobias Hepp; Laura Kalmbach; Manuel Kolb; Petros Martirosian; Tom Hilbert; Wolfgang M Thaiss; Mike Notohamiprodjo; Jens Bedke; Konstantin Nikolaou; Arnulf Stenzl; Stephan Kruck; Sascha Kaufmann
Journal:  World J Urol       Date:  2022-03-31       Impact factor: 3.661

4.  Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.

Authors:  Zhao-Yan Feng; Liang Wang; Xiang-De Min; Shao-Gang Wang; Guo-Ping Wang; Jie Cai
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.